| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025185 |
| Receipt No. | R000028275 |
| Official scientific title of the study | Evaluation of foods by using laboratory tests of human being who intake them |
| Date of disclosure of the study information | 2017/04/01 |
| Last modified on | 2018/12/14 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Evaluation of foods by using laboratory tests of human being who intake them | |
| Title of the study (Brief title) | Evaluation of foods by using laboratory tests of human being who intake them | |
| Region |
|
|
| Condition | |||
| Condition | nutrients deficiency, hypercholesterolemia, arteriosclerosis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | We usually evaluate the efficacy of foods by the constituents. However, the absorption efficacy is dependent on individuals and vary by individual.
We evaluate foods nutrients and fubctions by blood testing of humans who intake them. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | We evaluate the anti-oxidative effects of beta-carotene, the effects of zinc on enzyme activities and the effects of hydrogen molecule on the levels of cholesteroles. |
| Key secondary outcomes | monocyte, hsCRP |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | hydrogen enriched water, 900ml/day, for 8 weeks | |
| Interventions/Control_2 | vegetable juice, 200mlday, for 12 weeks | |
| Interventions/Control_3 | zinc supplement, 15 mg/day, for 20 days | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | LDL-C >120mg/dl
beta-carotene <20 ug/dl zinc <60 ug/dl |
|||
| Key exclusion criteria | under medical treatment | |||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Kazumasa Isobe |
| Organization | Institute of Medicine, Tsukuba University |
| Division name | Laboratory Medicine |
| Address | Tennodai 1-1-1, Tsukuba City, Ibaraki Prefecture |
| TEL | 029-853-3367 |
| k-isobe@md.tsukuba.ac.jp | |
| Public contact | |
| Name of contact person | Kazumasa Isobe |
| Organization | Institute of Medicine, Tsukuba University |
| Division name | Laboratory Medicine |
| Address | Tennodai 1-1-1, Tsukuba City, Ibaraki Prefecture |
| TEL | 029-853-3367 |
| Homepage URL | |
| k-isobe@md.tsukuba.ac.jp | |
| Sponsor | |
| Institute | Institute of Medicine, Tsukuba University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Institute of Medicine, Tsukuba University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 筑波大学医学医療系 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | Beta-carotene levels varied among individuals and correlated with their absorption ability.
Zinc levels also varied among individuals but not correlated with their pre-supplementaion levels. Anti-inflammatory, anti-oxidative effects of molecular hydrogen in healthy people were not observed. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000028275 |